Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial and host proteins refers to the collective set of proteins involved in the complex interface between a pathogen and its host, often referred to as the host-pathogen interactome (Casadevall & Pirofski, 2000). This broad category includes microbial virulence factors that manipulate host cell biology and host proteins that recognize or respond to these threats, such as Pattern Recognition Receptors (Janeway & Medzhitov, 2002). Because this term encompasses thousands of distinct molecules across diverse species, it does not constitute a single therapeutic target but rather a field of study (Dyer et al., 2008). In drug discovery, specific interactions within this group are targeted to inhibit pathogen entry, replication, or to modulate the host immune response (Finlay & Falkow, 1997). Examples of specific targets within this category include viral proteases or host-cell receptors like ACE2, but the collective term is too non-specific for drug labeling (Gordon et al., 2020). Consequently, this entry is classified as incorrect for the purposes of identifying a discrete molecular target in a pharmacological database. Understanding these interactions is crucial for developing anti-infectives and vaccines, but therapeutic intervention requires identifying specific, druggable nodes (Durmuş Tekir & Ülgen, 2013).
Not applicable as this is a broad category of proteins rather than a single target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial and host proteins.